# US 2016/0355537 A1 · Trioxacarcins and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0355537 A1
- Document ID: US20160355537A1
- Status: Published application
- Kind: A1
- Application number: 14/811,559
- Filed: 2015-07-28
- Published: 2016-12-08
- Earliest claimed: 2010-03-22
- Assignees: President and Fellows of Harvard College
- Applicants: President and Fellows of Harvard College
- Inventors: Andrew G. Myers; Nicholas E. Hill; Jakub Svenda; Robert T. Yu; Daniel J. Smaltz; Thomas Magauer
- Web page: https://patentgrep.com/patent/US20160355537A1

## CPC

- C07H 17/04: Heterocyclic radicals containing only oxygen as ring hetero atoms
- A61P 31/04: Antibacterial agents
- A61P 35/00: Antineoplastic agents
- C07D 493/22: in which the condensed system contains four or more hetero rings
- C07H 15/24: Condensed ring systems having three or more rings
- C07H 15/26: Acyclic or carbocyclic radicals, substituted by hetero rings
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The present invention relates to trioxacarcin compounds of the formula: or pharmaceutically acceptable forms thereof; wherein R1, R2, R3, R4, R5, R6, R7, R8, and R9 are as defined herein. The present invention also provides processes for preparing such compounds and intermediates thereto; pharmaceutical compositions comprising such compounds; and methods of use and treatment.

## Claims

### Claim 1

A compound of the Formula (I):
or a pharmaceutically acceptable form thereof;
wherein:
R1 is —ORA1; wherein each occurrence of RA1 is independently hydrogen; carbohydrate; a protecting group; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; acyl; substituted or unsubstituted aryl; or substituted or unsubstituted heteroaryl;
each occurrence of R and R is hydrogen;
R4 is hydrogen; halogen; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; —ORD1; —C(═O)RD2; —CO2RD2; —CN; —SCN; —SRD1; —SORD1; —SO2RD2; —NO2; —N3; —N(RD2)2; —NRD2C(═O)RD2; —NRD2C(═O)N(RD2)2; —OC(═O)ORD1; —OC(═O)RD2; —OC(═O)N(RD2)2; —NRD2C(═O)ORD1; or —C(RD2)3; wherein each occurrence of RD1 is independently hydrogen; carbohydrate; a protecting group; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; acyl; substituted or unsubstituted aryl; or substituted or unsubstituted heteroaryl; and wherein each occurrence of RD2 is independently hydrogen; carbohydrate; a protecting group; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; acyl; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; substituted hydroxyl; substituted thiol; amino; or substituted amino; or two RD2 groups are optionally joined to form a heterocyclyl or heteroaryl ring;
R5 is hydrogen; halogen; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; —ORE1; —C(═O)RE2; —CO2RE1; —CN; —SCN; —SRE1; —SORE1; —SO2RE2; —NO2; —N3; —N(RE2)2; —NRE2C(═O)RE2; —NRE2C(═O)N(RE2)2; —OC(═O)ORE1; —OC(═O)RE2; —OC(═O)N(RE2)2; —NRE2C(═O)ORE1; or —C(RE2)3; wherein each occurrence of RE1 is independently hydrogen; carbohydrate; a protecting group; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; acyl; substituted or unsubstituted aryl; or substituted or unsubstituted heteroaryl; and wherein each occurrence of RE2 is independently hydrogen; carbohydrate; a protecting group; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; acyl; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; substituted hydroxyl; substituted thiol; amino; or substituted amino; or two RE2 groups are optionally joined to form a heterocyclyl or heteroaryl ring;
R6 is hydrogen; halogen; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; —ORF1; —C(═O)RF2; —CO2RF1; —CN; —SCN; —SRF1; —SORF1; —SO2RF2; —NO2; —N3; —N(RF2)2; —NRF2C(═O)RF2; —NRF2C(═O)N(RF2)2; —OC(═O)ORF1; —OC(═O)RF2; —OC(═O)N(RF2)2; —NRF2C(═O)ORF1; or —C(RF2)3; wherein each occurrence of RF1 is independently hydrogen; carbohydrate; a protecting group; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; acyl; substituted or unsubstituted aryl; or substituted or unsubstituted heteroaryl; and wherein each occurrence of RF2 is independently hydrogen; carbohydrate; a protecting group; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; acyl; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; substituted hydroxyl; substituted thiol; amino; or substituted amino; or two RF2 groups are optionally joined to form a heterocyclyl or heteroaryl ring;
R7 is hydrogen; halogen; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; —ORG1; —C(═O)RG2; —CO2RG1; —CN; —SCN; —SRG1; —SORG1; —SO2RG2; —NO2; —N3; —N(RG2); —NRG2C(═O)RG2; —NRG2C(═O)N(RG2)2; —OC(═O)ORG1; —OC(═O)RG2; —OC(═O)N(RG2)2; —NRG2C(═O)ORG1; or —C(RG2)3; wherein each occurrence of RG1 is independently hydrogen; carbohydrate; a protecting group; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; acyl; substituted or unsubstituted aryl; or substituted or unsubstituted heteroaryl; and wherein each occurrence of RG2 is independently hydrogen; carbohydrate; a protecting group; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; acyl; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; substituted hydroxyl; substituted thiol; amino; or substituted amino; or two RG2 groups are optionally joined to form a heterocyclyl or heteroaryl ring;
R8 is —ORH1, wherein each occurrence of RH1 is independently hydrogen, carbohydrate, an oxygen-protecting group, cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; or acyl;
R9 is hydrogen; halogen; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; —ORI1; —C(═O)RI2; —CO2RI1; —CN; —SCN; —SRI1; —SORI1; —SO2RI2; —NO2; —N3; —N(RI2)2; —NRI2C(═O)RI2; —NRI2C(═O)N(RI2)2; —OC(═O)ORI1; —OC(═O)RI2; —OC(═O)N(RI2)2; —NRI2C(═O)ORI1; or —C(RI2)3; wherein each occurrence of RI1 is independently hydrogen; carbohydrate; a protecting group; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; acyl; substituted or unsubstituted aryl; or substituted or unsubstituted heteroaryl; and wherein each occurrence of RI2 is independently hydrogen; carbohydrate; a protecting group; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; acyl; substituted or unsubstituted aryl; or substituted or unsubstituted heteroaryl; substituted hydroxyl; substituted thiol; amino; or substituted amino; or two RI2 groups are optionally joined to form a heterocyclyl or heteroaryl ring;
or R1 and R4 are optionally taken together with the intervening carbon atoms to form an optionally substituted cyclic moiety;
or R4 and R7 are optionally be taken together with the intervening carbon atoms to form an optionally substituted cyclic moiety;
or R6 and R7 are optionally be taken together with the intervening carbon atoms to form an optionally substituted cyclic moiety.

### Claim 2 (depends on 1)

The compound of claim 1, wherein the compound is of the formula:
or a pharmaceutically acceptable form thereof.

### Claim at position 3

3-4. (canceled)

### Claim 5 (depends on 1)

The compound of claim 1, wherein the compound is of the formula:
or a pharmaceutically acceptable form thereof.

### Claim 6 (depends on 1)

The compound of claim 1, wherein R1 is —OH.

### Claim 7 (depends on 1)

The compound of claim 1, wherein R1 is —ORA1, wherein RA1 is a carbohydrate; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; acyl; substituted or unsubstituted aryl; or substituted or unsubstituted heteroaryl.

### Claim 8 (depends on 1)

The compound of claim 1, wherein R1 is —ORA1, wherein RA1 is a carbohydrate.

### Claim 9 (depends on 8)

The compound of claim 8, wherein the carbohydrate is:
wherein each occurrence of R is independently hydrogen, acyl, or C1-6 alkyl.

### Claim at position 9

10-16. (canceled)

### Claim 17 (depends on 1)

The compound of claim 1, wherein R4 is —ORD1, wherein RD1 is a carbohydrate; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; acyl; substituted or unsubstituted aryl; or substituted or unsubstituted heteroaryl.

### Claim 18 (depends on 1)

The compound of claim 1, wherein R4 is —OH.

### Claim 19

(canceled)

### Claim 20 (depends on 1)

The compound of claim 1, wherein R5 is —ORE1, wherein RE1 is a carbohydrate; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; acyl; substituted or unsubstituted aryl; or substituted or unsubstituted heteroaryl.

### Claim 21 (depends on 1)

The compound of claim 1, wherein R5 is —OH.

### Claim 22 (depends on 1)

The compound of claim 1, wherein R6 is C1-6 alkyl.

### Claim 23

(canceled)

### Claim 24 (depends on 1)

The compound of claim 1, wherein R7 is hydrogen.

### Claim at position 18

25-26. (canceled)

### Claim 27 (depends on 1)

The compound of claim 1, wherein R8 is —ORH1.

### Claim 28 (depends on 27)

The compound of claim 27, wherein RH1 is hydrogen, a carbohydrate, or C1-6alkyl.

### Claim 29 (depends on 28)

The compound of claim 28, wherein the carbohydrate is:
wherein Ra and Rb are independently selected from the group consisting of hydrogen; carbohydrate; an oxygen protecting group; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; acyl; substituted or unsubstituted aryl; or substituted or unsubstituted heteroaryl.

### Claim at position 22

30-31. (canceled)

### Claim 32 (depends on 1)

The compound of claim 1, wherein R9 is —CH(ORI3)2; and each occurrence of RI3 is independently hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or a carbohydrate.

### Claim at position 24

33-36. (canceled)

### Claim 37 (depends on 1)

The compound of claim 1, wherein R9 is —CH(OCH3)2.

### Claim at position 26

38-46. (canceled)

### Claim 47 (depends on 1)

A pharmaceutical composition comprising a compound of claim 1 or a pharmaceutically acceptable form thereof, and a pharmaceutically acceptable excipient.

### Claim 48 (depends on 1)

A method of treating a disease, disorder or condition selected from the group consisting of proliferative diseases, diabetic retinopathy, inflammatory diseases, autoimmune diseases, and infectious diseases, comprising administering to a subject an effective amount of a compound of claim 1 or pharmaceutically acceptable form thereof.

### Claim at position 29

49-51. (canceled)
